Choroidal Neovascularization in a Patient with Crohn's Disease

被引:2
作者
Casalino, Giuseppe [1 ]
Querques, Giuseppe [1 ]
Corvi, Federico [1 ]
Borrelli, Enrico [1 ]
Triolo, Giacinto [1 ]
Ramirez, Giuseppe Alvise [2 ]
Bandello, Francesco [1 ]
机构
[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Ophthalmol, Milan, Italy
[2] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Immunol, Milan, Italy
来源
CASE REPORTS IN OPHTHALMOLOGY | 2014年 / 5卷 / 02期
关键词
Choroidal neovascularization; Crohn's disease; Anti-VEGF; Intravitreal ranibizumab; Fluorescein angiography; Optical coherence tomography;
D O I
10.1159/000365881
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report a case of subfoveal choroidal neovascularization (CNV) in a patient with Crohn's disease (CD) and to discuss a possible association between these two conditions. Methods: This is an observational case report. Results: A 69-year-old male affected by CD was referred to our department because of sudden visual acuity drop in the left eye. A subfoveal CNV was diagnosed based on slit-lamp fundus biomicroscopy and fluorescein angiography. Color fundus photography, infrared autofluorescence and spectral-domain optical coherence tomography imaging of both eyes were also performed. Following six intravitreal ranibizumab injections, visual improvement was obtained with no related adverse events. Conclusion: We report a case of CNV as a possible rare extraintestinal manifestation of CD. The use of ranibizumab successfully impacted on CNV, while not affecting CD, which remained quiescent. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:249 / 254
页数:6
相关论文
共 16 条
[1]   The Effects of Infliximab or Adalimumab on Vascular Endothelial Growth Factor and Angiopoietin 1 Angiogenic Factor Levels in Inflammatory Bowel Disease: Serial Observations in 37 Patients [J].
Algaba, Alicia ;
Linares, Pablo M. ;
Encarnacion Fernandez-Contreras, M. ;
Figuerola, Ariadna ;
Calvet, Xavier ;
Guerra, Ivan ;
de Pousa, Ines ;
Chaparro, Maria ;
Gisbert, Javier P. ;
Bermejo, Fernando .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (04) :695-702
[2]   Crohn's disease [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2012, 380 (9853) :1590-1605
[3]   Feasibility of Anti-VEGF Agent Bevacizumab in Patients with Crohn's Disease [J].
Coriat, Romain ;
Mir, Olivier ;
Leblanc, Sarah ;
Ropert, Stanislas ;
Brezault, Catherine ;
Chaussade, Stanislas ;
Goldwasser, Francois .
INFLAMMATORY BOWEL DISEASES, 2011, 17 (07) :1632-1632
[4]   Mechanisms of disease: Age-related macular degeneration [J].
de Jong, Paulus T. V. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1474-1485
[5]   Innate and adaptive immunity in inflammatory bowel disease [J].
Geremia, Alessandra ;
Biancheri, Paolo ;
Allan, Philip ;
Corazza, Gino R. ;
Di Sabatino, Antonio .
AUTOIMMUNITY REVIEWS, 2014, 13 (01) :3-10
[6]  
Griga T, 1998, SCAND J GASTROENTERO, V33, P504
[7]  
Griga T, 1999, HEPATO-GASTROENTEROL, V46, P920
[8]   Role of angiogenesis in inflammatory bowel disease [J].
Koutroubakis, Ioannis E. ;
Tsiolakidou, Georgia ;
Karmiris, Konstantinos ;
Kouroumalis, Elias A. .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (06) :515-523
[9]   Iatrogenic choroidal neovascularization [J].
Lim, JI .
SURVEY OF OPHTHALMOLOGY, 1999, 44 (02) :95-111
[10]  
Loriot Y, 2008, ANN ONCOL, V19, DOI 10.1093/annonc/mdn566